Quarterly report pursuant to Section 13 or 15(d)

WARRANTS TO PURCHASE COMMON STOCK

v3.21.1
WARRANTS TO PURCHASE COMMON STOCK
3 Months Ended
Mar. 31, 2021
Stock Warrants Abstract  
WARRANTS TO PURCHASE COMMON STOCK

NOTE 13 – WARRANTS TO PURCHASE COMMON STOCK

The following table summarizes information with respect to outstanding warrants to purchase common stock of the Company at March 31, 2021:

 

Exercise     Number     Expiration
Price     Outstanding     Date
$ 0.50       24,920       November 2024  
$ 0.57       123,500       February 2025  
$ 35.00       490,571       December 2023  
$ 630.00       5,441          October 2021  
$ 687.50       474          October 2021  
          644,906          

 

During the quarter ended March 31, 2021, 3,400 warrants from the February 2020 Financing, with an exercise price of $0.57, were exercised for proceeds of approximately $2,000.

During the quarter ended March 31, 2020, 2.3 million warrants from the November 2019 Financing, with an exercise price of $0.57, were exercised for proceeds of approximately $1.3 million.

During the quarter ended March 31, 2020, 10.8 million warrants from the February 2020 Financing, with an exercise price of $0.57, were exercised for proceeds of approximately $6.2 million.